Heterologous live infectious bronchitis virus vaccination in day-old commercial broiler chicks: clinical signs, ciliary health, immune responses and protection against variant infectious bronchitis viruses

Groups of one-day-old broiler chicks were vaccinated via the oculo-nasal route with different live infectious bronchitis virus (IBV) vaccines: Massachusetts (Mass), 793B, D274 or Arkansas (Ark). Clinical signs and gross lesions were evaluated. Five chicks from each group were humanely killed at inte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Avian pathology 2016-03, Vol.45 (2), p.169-177
Hauptverfasser: Awad, Faez, Hutton, Sally, Forrester, Anne, Baylis, Matthew, Ganapathy, Kannan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 177
container_issue 2
container_start_page 169
container_title Avian pathology
container_volume 45
creator Awad, Faez
Hutton, Sally
Forrester, Anne
Baylis, Matthew
Ganapathy, Kannan
description Groups of one-day-old broiler chicks were vaccinated via the oculo-nasal route with different live infectious bronchitis virus (IBV) vaccines: Massachusetts (Mass), 793B, D274 or Arkansas (Ark). Clinical signs and gross lesions were evaluated. Five chicks from each group were humanely killed at intervals and their tracheas collected for ciliary activity assessment and for the detection of CD4+, CD8+ and IgA-bearing B cells by immunohistochemistry (IHC). Blood samples were collected at intervals for the detection of anti-IBV antibodies. At 21 days post-vaccination (dpv), protection conferred by different vaccination regimes against virulent M41, QX and 793B was assessed. All vaccination programmes were able to induce high levels of CD4+, CD8+ and IgA-bearing B cells in the trachea. Significantly higher levels of CD4+ and CD8+ expression were observed in the Mass ₂ + 793B ₂-vaccinated group compared to the other groups (subscripts indicate different manufacturers). Protection studies showed that the group of chicks vaccinated with Mass ₂ + 793B ₂ produced 92% ciliary protection against QX challenge; compared to 53%, 68% and 73% ciliary protection against the same challenge virus by Mass ₁ + D274, Mass ₁ + 793B ₁ and Mass ₃ + Ark, respectively. All vaccination programmes produced more than 85% ciliary protection against M41 and 793B challenges. It appears that the variable levels of protection provided by different heterologous live IBV vaccinations are dependent on the levels of local tracheal immunity induced by the respective vaccine combination. The Mass ₂ + 793B ₂ group showed the worst clinical signs, higher mortality and severe lesions following vaccination, but had the highest tracheal immune responses and demonstrated the best protection against all three challenge viruses.
doi_str_mv 10.1080/03079457.2015.1137866
format Article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_proquest_miscellaneous_1794505639</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4035095261</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-2820e3286816ed14f6dd0af9beccaab495977d1793ea17c30146286d8caa3a093</originalsourceid><addsrcrecordid>eNqNks9u1DAQxiMEoqXwCIAlLhyaxY4Tx-kJVAFFqsQBerZm7cmui2MvtnfRPiTvhMNuEeIAnPxnft_MePxV1VNGF4xK-opy2g9t1y8ayroFY7yXQtyrTlkruppzLu__tj-pHqV0SykVXdc8rE4a0becs-60-n6FGWNwYRW2iTi7Q2L9iDrb-byMweu1zTaRnY3lYgdaWw8l6gtHDOzr4AzRYZowagtulliHkRSZ_pIuiHbWW10Cya58OifaOgtxT9YILq_PiZ2mrUcSMW2CT5gIeEM2MeSfPXgCK7A-5VI5WvD5b91helw9GMElfHJcz6qbd28_X17V1x_ff7h8c13rdpC5bmRDkTdSSCbQsHYUxlAYhyVqDbBsh27oe8P6gSOwXnNaBlloI0uUAx34WfXykLc0-nWLKavJJo3OgcfSmWLz19BO8P9BJR9YI-WMvvgDvQ3b6MtDZqplgxQNLVR3oHQMKUUc1SbaqYxUMapma6g7a6jZGupojaJ7dsy-XU5ofqnuvFCA1wegjDjECb6F6IzKsHchjhG8tknxf9V4fkgxQlCwikVx86kQghaqoaLnPwAmX9bY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1784198620</pqid></control><display><type>article</type><title>Heterologous live infectious bronchitis virus vaccination in day-old commercial broiler chicks: clinical signs, ciliary health, immune responses and protection against variant infectious bronchitis viruses</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Awad, Faez ; Hutton, Sally ; Forrester, Anne ; Baylis, Matthew ; Ganapathy, Kannan</creator><creatorcontrib>Awad, Faez ; Hutton, Sally ; Forrester, Anne ; Baylis, Matthew ; Ganapathy, Kannan</creatorcontrib><description>Groups of one-day-old broiler chicks were vaccinated via the oculo-nasal route with different live infectious bronchitis virus (IBV) vaccines: Massachusetts (Mass), 793B, D274 or Arkansas (Ark). Clinical signs and gross lesions were evaluated. Five chicks from each group were humanely killed at intervals and their tracheas collected for ciliary activity assessment and for the detection of CD4+, CD8+ and IgA-bearing B cells by immunohistochemistry (IHC). Blood samples were collected at intervals for the detection of anti-IBV antibodies. At 21 days post-vaccination (dpv), protection conferred by different vaccination regimes against virulent M41, QX and 793B was assessed. All vaccination programmes were able to induce high levels of CD4+, CD8+ and IgA-bearing B cells in the trachea. Significantly higher levels of CD4+ and CD8+ expression were observed in the Mass ₂ + 793B ₂-vaccinated group compared to the other groups (subscripts indicate different manufacturers). Protection studies showed that the group of chicks vaccinated with Mass ₂ + 793B ₂ produced 92% ciliary protection against QX challenge; compared to 53%, 68% and 73% ciliary protection against the same challenge virus by Mass ₁ + D274, Mass ₁ + 793B ₁ and Mass ₃ + Ark, respectively. All vaccination programmes produced more than 85% ciliary protection against M41 and 793B challenges. It appears that the variable levels of protection provided by different heterologous live IBV vaccinations are dependent on the levels of local tracheal immunity induced by the respective vaccine combination. The Mass ₂ + 793B ₂ group showed the worst clinical signs, higher mortality and severe lesions following vaccination, but had the highest tracheal immune responses and demonstrated the best protection against all three challenge viruses.</description><identifier>ISSN: 1465-3338</identifier><identifier>ISSN: 0307-9457</identifier><identifier>EISSN: 1465-3338</identifier><identifier>DOI: 10.1080/03079457.2015.1137866</identifier><identifier>PMID: 26743315</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>Animals ; Animals, Newborn ; Antibodies, Viral - blood ; broiler chicks ; Bronchitis ; CD4 antigen ; CD8 antigen ; Chickens ; Coronavirus Infections - prevention &amp; control ; Coronavirus Infections - veterinary ; Enzyme-Linked Immunosorbent Assay - veterinary ; IBV ; immunity ; Immunity, Humoral ; Immunoglobulin A ; Immunohistochemistry ; Infectious bronchitis virus ; Infectious bronchitis virus - immunology ; Juveniles ; Lesions ; live vaccine ; Lymphocytes B ; Poultry ; Poultry Diseases - virology ; protection ; vaccination ; Vaccination - veterinary ; Vaccines ; Vaccines, Attenuated ; Viral Vaccines - immunology ; Viruses</subject><ispartof>Avian pathology, 2016-03, Vol.45 (2), p.169-177</ispartof><rights>2016 Houghton Trust Ltd 2016</rights><rights>2016 Houghton Trust Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-2820e3286816ed14f6dd0af9beccaab495977d1793ea17c30146286d8caa3a093</citedby><cites>FETCH-LOGICAL-c498t-2820e3286816ed14f6dd0af9beccaab495977d1793ea17c30146286d8caa3a093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26743315$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Awad, Faez</creatorcontrib><creatorcontrib>Hutton, Sally</creatorcontrib><creatorcontrib>Forrester, Anne</creatorcontrib><creatorcontrib>Baylis, Matthew</creatorcontrib><creatorcontrib>Ganapathy, Kannan</creatorcontrib><title>Heterologous live infectious bronchitis virus vaccination in day-old commercial broiler chicks: clinical signs, ciliary health, immune responses and protection against variant infectious bronchitis viruses</title><title>Avian pathology</title><addtitle>Avian Pathol</addtitle><description>Groups of one-day-old broiler chicks were vaccinated via the oculo-nasal route with different live infectious bronchitis virus (IBV) vaccines: Massachusetts (Mass), 793B, D274 or Arkansas (Ark). Clinical signs and gross lesions were evaluated. Five chicks from each group were humanely killed at intervals and their tracheas collected for ciliary activity assessment and for the detection of CD4+, CD8+ and IgA-bearing B cells by immunohistochemistry (IHC). Blood samples were collected at intervals for the detection of anti-IBV antibodies. At 21 days post-vaccination (dpv), protection conferred by different vaccination regimes against virulent M41, QX and 793B was assessed. All vaccination programmes were able to induce high levels of CD4+, CD8+ and IgA-bearing B cells in the trachea. Significantly higher levels of CD4+ and CD8+ expression were observed in the Mass ₂ + 793B ₂-vaccinated group compared to the other groups (subscripts indicate different manufacturers). Protection studies showed that the group of chicks vaccinated with Mass ₂ + 793B ₂ produced 92% ciliary protection against QX challenge; compared to 53%, 68% and 73% ciliary protection against the same challenge virus by Mass ₁ + D274, Mass ₁ + 793B ₁ and Mass ₃ + Ark, respectively. All vaccination programmes produced more than 85% ciliary protection against M41 and 793B challenges. It appears that the variable levels of protection provided by different heterologous live IBV vaccinations are dependent on the levels of local tracheal immunity induced by the respective vaccine combination. The Mass ₂ + 793B ₂ group showed the worst clinical signs, higher mortality and severe lesions following vaccination, but had the highest tracheal immune responses and demonstrated the best protection against all three challenge viruses.</description><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Antibodies, Viral - blood</subject><subject>broiler chicks</subject><subject>Bronchitis</subject><subject>CD4 antigen</subject><subject>CD8 antigen</subject><subject>Chickens</subject><subject>Coronavirus Infections - prevention &amp; control</subject><subject>Coronavirus Infections - veterinary</subject><subject>Enzyme-Linked Immunosorbent Assay - veterinary</subject><subject>IBV</subject><subject>immunity</subject><subject>Immunity, Humoral</subject><subject>Immunoglobulin A</subject><subject>Immunohistochemistry</subject><subject>Infectious bronchitis virus</subject><subject>Infectious bronchitis virus - immunology</subject><subject>Juveniles</subject><subject>Lesions</subject><subject>live vaccine</subject><subject>Lymphocytes B</subject><subject>Poultry</subject><subject>Poultry Diseases - virology</subject><subject>protection</subject><subject>vaccination</subject><subject>Vaccination - veterinary</subject><subject>Vaccines</subject><subject>Vaccines, Attenuated</subject><subject>Viral Vaccines - immunology</subject><subject>Viruses</subject><issn>1465-3338</issn><issn>0307-9457</issn><issn>1465-3338</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks9u1DAQxiMEoqXwCIAlLhyaxY4Tx-kJVAFFqsQBerZm7cmui2MvtnfRPiTvhMNuEeIAnPxnft_MePxV1VNGF4xK-opy2g9t1y8ayroFY7yXQtyrTlkruppzLu__tj-pHqV0SykVXdc8rE4a0becs-60-n6FGWNwYRW2iTi7Q2L9iDrb-byMweu1zTaRnY3lYgdaWw8l6gtHDOzr4AzRYZowagtulliHkRSZ_pIuiHbWW10Cya58OifaOgtxT9YILq_PiZ2mrUcSMW2CT5gIeEM2MeSfPXgCK7A-5VI5WvD5b91helw9GMElfHJcz6qbd28_X17V1x_ff7h8c13rdpC5bmRDkTdSSCbQsHYUxlAYhyVqDbBsh27oe8P6gSOwXnNaBlloI0uUAx34WfXykLc0-nWLKavJJo3OgcfSmWLz19BO8P9BJR9YI-WMvvgDvQ3b6MtDZqplgxQNLVR3oHQMKUUc1SbaqYxUMapma6g7a6jZGupojaJ7dsy-XU5ofqnuvFCA1wegjDjECb6F6IzKsHchjhG8tknxf9V4fkgxQlCwikVx86kQghaqoaLnPwAmX9bY</recordid><startdate>20160303</startdate><enddate>20160303</enddate><creator>Awad, Faez</creator><creator>Hutton, Sally</creator><creator>Forrester, Anne</creator><creator>Baylis, Matthew</creator><creator>Ganapathy, Kannan</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Ltd</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>7TM</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>F1W</scope><scope>H94</scope><scope>H95</scope><scope>K9.</scope><scope>L.G</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>20160303</creationdate><title>Heterologous live infectious bronchitis virus vaccination in day-old commercial broiler chicks: clinical signs, ciliary health, immune responses and protection against variant infectious bronchitis viruses</title><author>Awad, Faez ; Hutton, Sally ; Forrester, Anne ; Baylis, Matthew ; Ganapathy, Kannan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-2820e3286816ed14f6dd0af9beccaab495977d1793ea17c30146286d8caa3a093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Antibodies, Viral - blood</topic><topic>broiler chicks</topic><topic>Bronchitis</topic><topic>CD4 antigen</topic><topic>CD8 antigen</topic><topic>Chickens</topic><topic>Coronavirus Infections - prevention &amp; control</topic><topic>Coronavirus Infections - veterinary</topic><topic>Enzyme-Linked Immunosorbent Assay - veterinary</topic><topic>IBV</topic><topic>immunity</topic><topic>Immunity, Humoral</topic><topic>Immunoglobulin A</topic><topic>Immunohistochemistry</topic><topic>Infectious bronchitis virus</topic><topic>Infectious bronchitis virus - immunology</topic><topic>Juveniles</topic><topic>Lesions</topic><topic>live vaccine</topic><topic>Lymphocytes B</topic><topic>Poultry</topic><topic>Poultry Diseases - virology</topic><topic>protection</topic><topic>vaccination</topic><topic>Vaccination - veterinary</topic><topic>Vaccines</topic><topic>Vaccines, Attenuated</topic><topic>Viral Vaccines - immunology</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Awad, Faez</creatorcontrib><creatorcontrib>Hutton, Sally</creatorcontrib><creatorcontrib>Forrester, Anne</creatorcontrib><creatorcontrib>Baylis, Matthew</creatorcontrib><creatorcontrib>Ganapathy, Kannan</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Avian pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Awad, Faez</au><au>Hutton, Sally</au><au>Forrester, Anne</au><au>Baylis, Matthew</au><au>Ganapathy, Kannan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heterologous live infectious bronchitis virus vaccination in day-old commercial broiler chicks: clinical signs, ciliary health, immune responses and protection against variant infectious bronchitis viruses</atitle><jtitle>Avian pathology</jtitle><addtitle>Avian Pathol</addtitle><date>2016-03-03</date><risdate>2016</risdate><volume>45</volume><issue>2</issue><spage>169</spage><epage>177</epage><pages>169-177</pages><issn>1465-3338</issn><issn>0307-9457</issn><eissn>1465-3338</eissn><abstract>Groups of one-day-old broiler chicks were vaccinated via the oculo-nasal route with different live infectious bronchitis virus (IBV) vaccines: Massachusetts (Mass), 793B, D274 or Arkansas (Ark). Clinical signs and gross lesions were evaluated. Five chicks from each group were humanely killed at intervals and their tracheas collected for ciliary activity assessment and for the detection of CD4+, CD8+ and IgA-bearing B cells by immunohistochemistry (IHC). Blood samples were collected at intervals for the detection of anti-IBV antibodies. At 21 days post-vaccination (dpv), protection conferred by different vaccination regimes against virulent M41, QX and 793B was assessed. All vaccination programmes were able to induce high levels of CD4+, CD8+ and IgA-bearing B cells in the trachea. Significantly higher levels of CD4+ and CD8+ expression were observed in the Mass ₂ + 793B ₂-vaccinated group compared to the other groups (subscripts indicate different manufacturers). Protection studies showed that the group of chicks vaccinated with Mass ₂ + 793B ₂ produced 92% ciliary protection against QX challenge; compared to 53%, 68% and 73% ciliary protection against the same challenge virus by Mass ₁ + D274, Mass ₁ + 793B ₁ and Mass ₃ + Ark, respectively. All vaccination programmes produced more than 85% ciliary protection against M41 and 793B challenges. It appears that the variable levels of protection provided by different heterologous live IBV vaccinations are dependent on the levels of local tracheal immunity induced by the respective vaccine combination. The Mass ₂ + 793B ₂ group showed the worst clinical signs, higher mortality and severe lesions following vaccination, but had the highest tracheal immune responses and demonstrated the best protection against all three challenge viruses.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>26743315</pmid><doi>10.1080/03079457.2015.1137866</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1465-3338
ispartof Avian pathology, 2016-03, Vol.45 (2), p.169-177
issn 1465-3338
0307-9457
1465-3338
language eng
recordid cdi_proquest_miscellaneous_1794505639
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Animals, Newborn
Antibodies, Viral - blood
broiler chicks
Bronchitis
CD4 antigen
CD8 antigen
Chickens
Coronavirus Infections - prevention & control
Coronavirus Infections - veterinary
Enzyme-Linked Immunosorbent Assay - veterinary
IBV
immunity
Immunity, Humoral
Immunoglobulin A
Immunohistochemistry
Infectious bronchitis virus
Infectious bronchitis virus - immunology
Juveniles
Lesions
live vaccine
Lymphocytes B
Poultry
Poultry Diseases - virology
protection
vaccination
Vaccination - veterinary
Vaccines
Vaccines, Attenuated
Viral Vaccines - immunology
Viruses
title Heterologous live infectious bronchitis virus vaccination in day-old commercial broiler chicks: clinical signs, ciliary health, immune responses and protection against variant infectious bronchitis viruses
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T16%3A32%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heterologous%20live%20infectious%20bronchitis%20virus%20vaccination%20in%20day-old%20commercial%20broiler%20chicks:%20clinical%20signs,%20ciliary%20health,%20immune%20responses%20and%20protection%20against%20variant%20infectious%20bronchitis%20viruses&rft.jtitle=Avian%20pathology&rft.au=Awad,%20Faez&rft.date=2016-03-03&rft.volume=45&rft.issue=2&rft.spage=169&rft.epage=177&rft.pages=169-177&rft.issn=1465-3338&rft.eissn=1465-3338&rft_id=info:doi/10.1080/03079457.2015.1137866&rft_dat=%3Cproquest_infor%3E4035095261%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1784198620&rft_id=info:pmid/26743315&rfr_iscdi=true